Vor BiopharmaVOR
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 45 institutions reported holding Vor Biopharma Inc. (VOR) in their 13F filings, down 7 from Q4 2024. 9 opened new positions and 15 sold out. The largest holders were Ra Capital Management, L.P. ($28.4M), FMR LLC ($4.6M) and 5AM Venture Management, LLC ($4.6M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Vor Biopharma Inc.
- CUSIP
- 929033108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $331K |
| Exits | 15 | $1.7M |
All 13F filers, Q4 2024 → Q1 2025: 1,104,817 shares bought and 1,960,821 shares sold, net −856,004 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Ra Capital Management, L.P. | 0.48% | No change | 39,646,039 | $28.4M |
| FMR LLC | 0.00% | Add +0.0% | 6,422,496 | $4.6M |
| 5AM Venture Management, LLC | 1.73% | No change | 6,361,723 | $4.6M |
| Vanguard Group Inc. | 0.00% | Reduce -0.1% | 1,940,223 | $1.4M |
| Johnson & Johnson | 0.23% | No change | 1,074,658 | $771K |
| Renaissance Technologies | 0.00% | Add +32.5% | 701,431 | $503K |
| Sarissa Capital Management LP | 0.24% | Reduce -17.8% | 508,016 | $365K |
| BlackRock, Inc. | 0.00% | Reduce -0.8% | 484,506 | $348K |
| Geode Capital Management, LLC | 0.00% | Add +3.8% | 438,010 | $314K |
| Susquehanna International Group, LLP | 0.00% | Add +234.1% | 384,293 | $276K |
| MAI Capital Management | 0.00% | Add +1.8% | 288,363 | $207K |
| Jane Street Group, LLC | 0.00% | New | 194,756 | $140K |
| Millennium Management | 0.00% | Reduce -28.6% | 186,849 | $134K |
| Exchange Traded Concepts, LLC | 0.00% | Reduce -10.7% | 148,073 | $106K |
| Northern Trust Corp. | 0.00% | Reduce -6.7% | 147,022 | $105K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 139,600 | $100K |
| Two Sigma Investments, LP | 0.00% | Reduce -24.6% | 122,991 | $88K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -8.8% | 120,900 | $87K |
| State Street Corp. | 0.00% | No change | 115,934 | $83K |
| Barclays PLC | 0.00% | Add +804.7% | 99,739 | $72K |
| Trustees of Columbia University in the City of New York | 0.01% | No change | 91,910 | $66K |
| Goldman Sachs Group Inc. | 0.00% | Add +218.2% | 84,945 | $61K |
| Bollard Group LLC | 0.00% | No change | 55,555 | $40K |
| Money Concepts Capital Corp. | 0.00% | Add +106.1% | 51,535 | $37K |
| Qube Research & Technologies Ltd | 0.00% | New | 48,196 | $35K |
| HSBC Holdings PLC | 0.00% | No change | 44,728 | $33K |
| Morgan Stanley | 0.00% | Reduce -77.8% | 35,441 | $25K |
| Jain Global LLC | 0.00% | New | 24,054 | $17K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 0.00% | Reduce -30.8% | 20,773 | $15K |
| Marshall Wace, LLP | 0.00% | Reduce -49.8% | 18,668 | $13K |
| United Bank | 0.00% | No change | 15,300 | $11K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 13,425 | $10K |
| Gsa Capital Partners LLP | 0.00% | New | 11,859 | $9K |
| Catalyst Funds Management Pty Ltd | 0.00% | New | 10,764 | $8K |
| Chicago Partners Investment Group LLC | 0.00% | New | 12,731 | $7K |
| UBS Group AG | 0.00% | New | 8,455 | $6K |
| Simplex Trading, LLC | 0.00% | Add +52.3% | 6,959 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -4.3% | 3,448 | $2K |
| Federated Hermes, Inc. | 0.00% | Reduce -34.8% | 1,985 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -82.6% | 1,859 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -11.5% | 1,017 | $730 |
| Group One Trading LLC | 0.00% | Reduce -72.0% | 678 | $486 |
| Bank of America Corp. | 0.00% | Reduce -76.6% | 560 | $402 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -72.3% | 133 | $95 |
| Royal Bank of Canada | 0.00% | No change | 55 | $0 |
"% of holder's portfolio" is VOR's weight in each manager's 13F, not the share of Vor Biopharma Inc. the manager owns.